Real wOrld studY in the Adjuvant Setting for High Risk earLy Breast Cancer Patients

The primary goal of this observational study is to describe the distribution of treatment options and patients' characteristics according to the definition of high-risk status in the early breast cancer (EBC) setting. Participants already taking intervention as part of their regular medical care for EBC will answer questionnaires to also assess quality of life and patient reported outcomes. The recruitment phase will last about 2 years, each patient will be followed up for 5 years.

NCT Number	NCT07151911
Lead Sponsor	Azienda Ospedaliero-Universitaria di Modena
Conditions	Breast Cancer
Enrollment	100 participants
Start Date	2024-08-26
Primary Completion	2026-09 (estimated)
Study Completion	2031-09 (estimated)
Updated on ClinicalTrials.gov	2025-09-03